Xue Shan

411 total citations
12 papers, 335 citations indexed

About

Xue Shan is a scholar working on Molecular Biology, Immunology and Allergy and Immunology. According to data from OpenAlex, Xue Shan has authored 12 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and Allergy and 4 papers in Immunology. Recurrent topics in Xue Shan's work include Immunotherapy and Immune Responses (4 papers), RNA Interference and Gene Delivery (4 papers) and Cell Adhesion Molecules Research (4 papers). Xue Shan is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), RNA Interference and Gene Delivery (4 papers) and Cell Adhesion Molecules Research (4 papers). Xue Shan collaborates with scholars based in China, Norway and United States. Xue Shan's co-authors include Xinghai Ning, Leilei Guo, Qing Jiang, Ran Li, Hong Liu, Bo Zhou, Jing Han, Fei Lin, Ming Shen and Xia Meng and has published in prestigious journals such as PLoS ONE, Biomaterials and Analytical Chemistry.

In The Last Decade

Xue Shan

12 papers receiving 329 citations

Peers

Xue Shan

MB

CR

BE

ID

IMMUN

Shufen Xu China

Dan Yin China

Marcos Vinícios Salles Dias Brazil

Shahrokh M. Ghobadloo Canada

Vicenta Trujillo-Alonso United States

Michelle F. Maritz Australia

Xiaodan Li China

Rabeb Mouna Derbali Canada

Benedetta Santini Italy

Shufen Xu China

Xue Shan

290 ×1.8

MB

101 ×1.0

CR

55 ×0.6

BE

23 ×0.4

ID

53 ×1.2

IMMUN

Citations per year, relative to Xue Shan Xue Shan (= 1×) peers Shufen Xu

Countries citing papers authored by Xue Shan

Since Specialization

Citations

This map shows the geographic impact of Xue Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Shan more than expected).

Fields of papers citing papers by Xue Shan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Shan. The network helps show where Xue Shan may publish in the future.

Co-authorship network of co-authors of Xue Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Shan. A scholar is included among the top collaborators of Xue Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Shan. Xue Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Zeng, Zhen, Jun Yao, Ying Xue, et al.. (2021). The Role of the lncRNA-LRCF in Propofol-Induced Oligodendrocyte Damage in Neonatal Mouse. Neurochemical Research. 46(4). 778–791. 9 indexed citations

2.

Li, Shujun, et al.. (2021). The benefits of surgery plus extensive intraoperative peritoneal lavage (EIPL) for patients with gastric cancer compared with surgery alone: a systematic review and meta-analysis. Updates in Surgery. 74(1). 65–72. 5 indexed citations

3.

Shan, Xue, Lei Zhang, Yurui Xu, et al.. (2020). An octopus-mimic PEGylated peptide as a specific integrin αvβ3 inhibitor for preventing tumor progression. Chemical Communications. 56(14). 2178–2181. 6 indexed citations

4.

Gu, Tingting, Chengjun Li, Yurui Xu, et al.. (2020). Stimuli-responsive combination therapy of cisplatin and Nrf2 siRNA for improving antitumor treatment of osteosarcoma. Nano Research. 13(3). 630–637. 17 indexed citations

5.

Guo, Leilei, Yurui Xu, Anwei Zhou, et al.. (2019). A stimuli-responsive combination therapy for recovering p53-inactivation associated drug resistance. Materials Science and Engineering C. 108. 110403–110403. 12 indexed citations

6.

Zhang, Lei, Leilei Guo, Xue Shan, et al.. (2019). An elegant nitroreductase responsive fluorescent probe for selective detection of pathogenic Listeria in vitro and in vivo. Talanta. 198. 472–479. 22 indexed citations

7.

Zhang, Lei, Xue Shan, Xia Meng, et al.. (2019). The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer. Biomaterials. 223. 119471–119471. 19 indexed citations

8.

Zhang, Lei, Xia Meng, Xue Shan, et al.. (2019). Integrin αvβ3-Specific Hydrocyanine for Cooperative Targeting of Glioblastoma with High Sensitivity and Specificity. Analytical Chemistry. 91(19). 12587–12595. 13 indexed citations

9.

Huang, Xinyu, Meng Li, Yurui Xu, et al.. (2019). Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus. ACS Applied Materials & Interfaces. 11(22). 19799–19807. 76 indexed citations

10.

Zhang, Lei, Xue Shan, Xia Meng, et al.. (2019). Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma. Molecular Pharmaceutics. 16(9). 3977–3984. 19 indexed citations

11.

Zhang, Lei, Xue Shan, Leilei Guo, et al.. (2018). A sensitive and fast responsive fluorescent probe for imaging hypoxic tumors. The Analyst. 144(1). 284–289. 13 indexed citations

12.

Lin, Fei, Ran Li, Bo Zhou, et al.. (2012). miR-26b Promotes Granulosa Cell Apoptosis by Targeting ATM during Follicular Atresia in Porcine Ovary. PLoS ONE. 7(6). e38640–e38640. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact